The global preeclampsia diagnostics market is prognosticated to experience a wider adoption during the forecast period from 2017 to 2025. Transparency Market Research has recently published a report titled, “Preeclampsia Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.” Preeclampsia is a hypertensive pregnancy disorder, which affects around 5% of women all around the world. Out of these, only 0.5% to 1% suffer the severity of it.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32423
The global preeclampsia diagnostics market is classified into instrument, test type, and end-user. On the basis of test type, the preeclampsia diagnostics market is divided into immunoassay and biomarker. The immunoassay (ELISA) segment is further sub-divided into DELFIA Xpress PlGF kit2 and Elecsys PIGF/sFLT-1. The immunoassay test helps in early and accurate diagnosis of preeclampsia. The biomarker segment also sub-divided into vascular endothelial growth factor (VEGF), placental growth factor (PlGF), soluble endoglin (sEng), pregnancy associated plasma protein-A (PAPP-A), soluble Fms-like tyrosine kinase -1(sFlt-1), neutrophil gelatinase-associated lipocalin (NGAL), placental protein 13(PP-13), and so on.
As per instrument, the global preeclampsia diagnostics market is sectioned into AutoDELFIA immunoassay system for prenatal screening, Victor2 D Instrument, and so forth. Based on end-user, the global preeclampsia diagnostics market is segmented into specialty clinics, hospitals, research centers, diagnostics laboratories, and others. The diagnostics laboratories segment accounted for major market share in year 2016. The specialty clinics segment is foreseen to register significant growth in coming years. Geographically, North America is anticipated to register for high market share of the overall preeclampsia diagnostics market, due to the upgradation in diagnostic tests and rise in number of cases with pregnancy related illnesses. DRG INSTRUMENTS GMBH, Roche, PerkinElmer Inc., Siemens AG, Diabetomics, Inc., and LionsGate Technologies Inc. are among the key players reigning in the global preeclampsia diagnostics market.